Shenzhen presents $630m plan to increase AI, robotics - The Tamesis

Assistance consists of version qualifications, corpus qualifications and scenario-based aids to boost AI and robotics.

Post Views: 97

Tags

Related Posts

Can Japan PM Takaichi build a system to advance policy measures?: The Yomiuri Shimbun

January 21, 2026

Singapore’s biomedical sector is expected to benefit after a sharp rise in pharmaceutical production, as companies anticipate US trade policy changes.

January 20, 2026

Singapore’s biomedical sector is expected to benefit after a sharp rise in pharmaceutical production, as companies anticipate US trade policy changes.

January 19, 2026

The Tamesis

Leave a Reply Cancel reply

Latest from Blog

Caretaker politics – Asia News NetworkAsia News Network

Gold To Keep Rising As Trust Flies Out The Window

Christie’s Koch Sale Signals Renewed Interest in American Art

Celebrated Gallerist Marian Goodman Dies at 97

Alissa Friedman on Salon 94 and the Blurring of Art and Design

6 Slow-Burn Romances to Watch If You’re Still Not Over ‘Heated Rivalry’

What Doctors Wish You Knew About ‘Healing’ Your Gut

7 All-Black Outfit Ideas to Copy This Winter

‘Nobody is safe’: Chinese President Xi targets his close ally in purge

American Academy of Pediatrics releases vaccine recommendations that differ from CDC guidance

Related Posts

Can Japan PM Takaichi build a system to advance policy measures?: The Yomiuri Shimbun

January 21, 2026

Singapore’s biomedical sector is expected to benefit after a sharp rise in pharmaceutical production, as companies anticipate US trade policy changes.

January 20, 2026

Singapore’s biomedical sector is expected to benefit after a sharp rise in pharmaceutical production, as companies anticipate US trade policy changes.

January 19, 2026

Don't Miss

Can Japan PM Takaichi build a system to advance policy measures?: The Yomiuri Shimbun

January 21, 2026 Tokyo – “I

Singapore’s biomedical sector is expected to benefit after a sharp rise in pharmaceutical production, as companies anticipate US trade policy changes.

Singapore’s biopharmaceutical industry is expected to